Answers are grounded in this paper and cite their sources.
This framework integrates immune modulation and neural reprogramming to restore remyelination in chronic multiple sclerosis lesions, suggesting new therapeutic pathways.
Chronic multiple sclerosis (MS) lesions are characterized by persistent demyelination and a failure of endogenous repair mechanisms, particularly remyelination. Despite advances in immunomodulatory therapies, effective strategies targeting neural repair remain limited. This work introduces a precision conceptual framework aimed at restoring remyelination in chronic MS lesions by integrating immune modulation with targeted neural and glial reprogramming. The framework focuses on overcoming key biological barriers such as oligodendrocyte progenitor cell dysfunction, inhibitory lesion microenvironments, and chronic neuroinflammation. By emphasizing targeted, lesion-specific intervention strategies, this approach seeks to bridge the gap between immunological disease control and true neural repair. This framework may inform future translational research and therapeutic development for progressive and chronic forms of multiple scle rosis.
No takes yet. Share an insight, caveat, or question.
Mahdieh Mahdieh Abbasian (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: